NEW YORK (360Dx) – Diagnostics companies have shown a high level of interest in the European Commission's Horizon 2020 program focused on test development, with a focus on cancer, infectious diseases, and circulatory diseases dominating the submitted projects.

Of the 1,194 Horizon 2020 proposals received between 2014 and 2017, most were related to the development of markers and devices for in vitro diagnostics, while a third were focused on personalized medicine.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

Already a 360Dx Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.